Rethinking gene therapy for X-linked retinoschisis: from vitreous to subretinal space
In a recent study published in The New England Journal of Medicine, Liang and colleagues report that subretinal delivery of scAAV8-hRS1 to 12 children with X-linked retinoschisis (XLRS) resulted in closure of macular schisis by 13 weeks in all treated eyes and restoration of outer retinal structure in most participants. 1 These findings provide encouraging evidence that RS1 gene augmentation can substantially improve retinal structure in X-linked retinoschisis, while raising the important question of whether anatomical rescue will translate into meaningful and durable improvements in visual function.
Authors
- John Grigg (ORCID: https://orcid.org/0000-0002-6763-8119)
- Robyn V. Jamieson (ORCID: https://orcid.org/0000-0002-7285-0253)
- Samantha L. Ginn (ORCID: https://orcid.org/0000-0002-0876-6292)
Institutions
- The University of Sydney (AU)
- Children's Medical Research Institute (AU)
- Sydney Children's Hospital (AU)
- Sydney Children’s Hospitals Network (AU)
Publication Details
- Journal
- Signal Transduction and Targeted Therapy
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41392-026-03090-9
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00